Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

PPAPDC3 Activators

PPAPDC3 activators are a diverse group of compounds that exert their influence via various biochemical mechanisms, ultimately leading to the increased activity of this lipid phosphatase. For example, certain activators work by binding to and activating adenylate cyclase, which in turn increases intracellular cAMP levels. This rise in cAMP can enhance the functional activity of PPAPDC3 by altering lipid signaling pathways, a process that is crucial for maintaining cellular homeostasis. Other activators directly engage with protein kinase C, leading to the phosphorylation of proteins that are part of the signaling cascades in which PPAPDC3 is involved. This phosphorylation can modify the activity of PPAPDC3, integrating it more effectively into cellular signaling.

Some activators influence intracellular calcium levels, which is a key factor in various signaling pathways, including those that could affect PPAPDC3. By mobilizing calcium stores or facilitating calcium influx into the cell, these activators indirectly modulate the activity of PPAPDC3 within calcium-mediated phospholipid signaling pathways. Alternatively, certain sphingosine analogs and sphingosine-1-phosphate activators can modulate sphingolipid signaling pathways, impacting PPAPDC3 function. Other compounds can increase intracellular NAD+ levels, which, while not directly interacting with PPAPDC3, could influence its activity through alterations in cellular metabolism. Additionally, some activators can modify the eicosanoid synthesis pathway, which is closely related to phospholipid signaling, thereby indirectly affecting PPAPDC3's role within these pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C (PKC) which can phosphorylate proteins in pathways that PPAPDC3 is involved in.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Increases intracellular calcium, potentially affecting calcium-dependent phospholipid signaling involving PPAPDC3.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

Mobilizes intracellular calcium stores, indirectly influencing PPAPDC3 activity in calcium-mediated pathways.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist that raises cAMP levels, thereby possibly enhancing PPAPDC3 activity through lipid signaling.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Inhibits phosphodiesterases, elevating cAMP and potentially increasing PPAPDC3 activity via lipid signaling pathways.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

cAMP analog that bypasses receptors and directly activates cAMP-dependent pathways, potentially activating PPAPDC3.

FTY720

162359-56-0sc-202161
sc-202161A
sc-202161B
1 mg
5 mg
25 mg
$33.00
$77.00
$120.00
14
(1)

Sphingosine analogue that after phosphorylation can influence sphingosine-1-phosphate (S1P) signaling impacting PPAPDC3.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Activates S1P receptors, potentially influencing PPAPDC3 function in sphingolipid signaling pathways.

Nicotinic Acid

59-67-6sc-205768
sc-205768A
250 g
500 g
$62.00
$124.00
1
(1)

Raises intracellular levels of nicotinamide adenine dinucleotide (NAD+), which could indirectly affect PPAPDC3 activity.

Arachidonic Acid (20:4, n-6)

506-32-1sc-200770
sc-200770A
sc-200770B
100 mg
1 g
25 g
$92.00
$240.00
$4328.00
9
(1)

Precursor in eicosanoid synthesis, can modulate phospholipid signaling pathways that involve PPAPDC3.